Influence of insulin resistance on adiponectin receptor expression in breast cancer.
OBJECTIVE
Adipositas and insulin resistance are modifiable risk factors for breast cancer. Adiponectin seems to be an important linkage of these associations. In this study, we investigated the relationship between intratumoral adiponectin receptor expression and insulin resistance as well as intratumoral insulin/IGF receptor expression in breast cancer specimen.


METHODS
Breast cancer tissue and fasting serum were collected from 26 female patients. After microdissection of frozen samples, RNA was isolated and expression of insulin receptor, IGFR1, IGFR2, AdipoR1 and AdipoR2 was measured on mRNA level by means of real time RT-PCR. Fasting insulin, glucose and c-peptide serum levels were analysed by ELISA. Insulin resistance was calculated using the HOMA model.


RESULTS
We were able to confirm AdipoR1 and AdipoR2 expression, respectively, in breast cancer specimen. Actually, neither insulin serum level nor whole-body insulin resistance showed any effect on insulin/IGF or adiponectin receptor expression in breast cancer. A strong positive correlation between insulin as well as IGF1 receptor and AdipoR1, but not AdipoR2, expression could be observed. Interestingly, AdipoR2 expression significantly correlated with vascular and lymphovascular invasion of breast cancer.


CONCLUSIONS
We propose a close relationship between the intratumoral insulin signalling system and AdipoR1 but not AdipoR2 expression. As AdipoR2 but not AdipoR1 expression seems to correlate with invasiveness, we assume different functions of the two adiponectin receptors in breast cancer.
Pfeiler
Georg
G
Department of Obstetrics and Gynecology, University of Regensburg, 93042 Regensburg, Germany.
Treeck
Oliver
O
Wenzel
Gitte
G
Goerse
Regina
R
Hartmann
A
A
Schmitz
Gerd
G
Ortmann
Olaf
O
D000367:Age Factors; D015992:Body Mass Index; D001943:Breast Neoplasms / Q000209:etiology / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics / Q000502:physiology*; D008207:Lymphatic Metastasis / Q000235:genetics; D009765:Obesity / Q000150:complications / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D017526:Receptor, IGF Type 1 / Q000235:genetics / Q000378:metabolism*; D011972:Receptor, Insulin / Q000235:genetics / Q000378:metabolism*; D054419:Receptors, Adiponectin / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction
C475418:ADIPOR1 protein, human; C475420:ADIPOR2 protein, human; D012333:RNA, Messenger; D054419:Receptors, Adiponectin; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin